50.91
前日終値:
$50.14
開ける:
$50.6
24時間の取引高:
108.71K
Relative Volume:
0.86
時価総額:
$2.23B
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-0.29%
1か月 パフォーマンス:
+6.62%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
Anbio Biotechnology Stock (NNNN) Company Profile
NNNN を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
NNNN
Anbio Biotechnology
|
50.91 | 2.20B | 0 | 0 | 0 | 0.00 |
![]()
ISRG
Intuitive Surgical Inc
|
480.26 | 171.02B | 9.15B | 2.63B | 1.99B | 7.17 |
![]()
BDX
Becton Dickinson Co
|
195.94 | 55.89B | 21.39B | 1.61B | 2.55B | 5.56 |
![]()
ALC
Alcon Inc
|
87.71 | 42.93B | 9.93B | 1.12B | 1.43B | 2.26 |
![]()
RMD
Resmed Inc
|
284.89 | 41.69B | 5.15B | 1.40B | 1.65B | 9.51 |
![]()
WST
West Pharmaceutical Services Inc
|
246.20 | 17.70B | 2.90B | 467.20M | 306.90M | 6.37 |
Anbio Biotechnology (NNNN) 最新ニュース
The Unlocking of Voting Control in Anbio Biotechnology: A Post-Lock-Up Opportunity in a Dual-Class IPO - AInvest
Anbio Biotechnology's Post-Lock-Up Investment Implications: Unlocking Shareholder Value and Market Dynamics - AInvest
Certain Class B Ordinary Shares of Anbio Biotechnology are subject to a Lock-Up Agreement Ending on 18-AUG-2025. - MarketScreener
Will Aquestive Therapeutics Inc. price bounce be sustainablePortfolio Growth Summary & High Accuracy Swing Entry Alerts - Newser
Can MNTK expand its profit marginsMarket Trend Review & AI Forecasted Stock Moves - thegnnews.com
CompanyInsider Selling & Reliable Breakout Stock Forecasts - Newser
Zhengye Skyrocketed 33.84%—What’s Fueling This Biotech Breakout? - AInvest
Will The Southern Company Preferred Security benefit from macro trendsMulti-Year Signal Summary and Entry Timing - Newser
enCore Energy Corp. stock prediction for this weekFree ROI Boosting Trade Opportunity Calendar - Newser
Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System - digitalmore.co
Anbio Biotechnology's Strategic Expansion into Point-of-Care Diagnostics: A High-Growth Opportunity in Global Infectious Disease Management - AInvest
Breakthrough: Anbio's 15-Minute PCR System and Chikungunya Test Transform Disease Detection - Stock Titan
Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System - GlobeNewswire Inc.
Why Coherus BioSciences Inc. stock attracts strong analyst attentionSummary of Trade Cycles in 5-Year Range - Newser
Full technical analysis of AFSC stockEarnings Based Stock Performance Forecast - Newser
Anbio Biotechnology (NNNN) Surges 13% in Dramatic Intraday Rally – What’s Fueling the Momentum? - AInvest
7 healthtech scaleups to watch in Europe & UK in 2025 - Tech Funding News
Is FORR stock bottoming outCapital Growth Plan for New Investors - Newser
Will Intuitive Machines Inc. stock recover after recent dropIntraday Movement Recap and Chart Summary - Newser
IRBT stock daily chart insightsDownside Control Plan With Support Analysis - Newser
Why UGRO stock attracts strong analyst attentionFree Early Entry Tips With Low Risk Zone - Newser
BAC.PRCC stock prediction for this weekFree Smart Money Tracking Signal Generator - Newser
Price momentum metrics for Iterum Therapeutics plc explainedEarly Entry Ideas with Momentum Potential - Newser
What Anbio Biotechnology's (NASDAQ:NNNN) ROE Can Tell Us - simplywall.st
Is a relief rally coming for BriaCell Therapeutics Corp. Equity Warrant holdersFree Stock Selection With High Accuracy - Newser
How to escape a deep drawdown in HTOOFree Pattern Breakout Entry Stock Forecast - Newser
Has ESLT formed a bullish divergenceFree Short Term Buy List With Stop Protection - Newser
Why CARGO Therapeutics Inc. stock attracts strong analyst attentionAI Trading Forecast Based on Big Data - Newser
What momentum shifts mean for C.PRGCSwing Reversal Forecast Based on Patterns - Newser
Is Enigmatig Limited stock bottoming outFree Trade Timing Strategy With Technical Data - Newser
How many analysts rate Anbio Biotechnology as a “Buy”Swing Trade Report For Consistent Profits - Jammu Links News
Risk vs reward if holding onto Anbio BiotechnologyEarnings Report Summary with Market Impact - Newser
Sentiment analysis tools applied to DHT Holdings Inc.Free Accurate Technical Trend Reversal Picks - Newser
What makes Anbio Biotechnology stock price move sharplyFree Fundamental Growth Stock Analysis - Newser
Using R and stats models for Otis Worldwide Corporation forecastingAlgorithmic Forecast for Swing Trading Picks - Newser
What catalysts could drive Anbio Biotechnology stock higher in 2025Top Growth Data Feed From AI Tools - Jammu Links News
What is Anbio Biotechnology company’s growth strategyPost Market Opportunities With High Returns - Jammu Links News
Applying sector rotation models to Signing Day Sports Inc.Free Access to Smart Investment Tips - Newser
Why Anbio Biotechnology stock attracts strong analyst attentionMomentum Screener with Buy and Sell Areas - Newser
Institutional scanner results for Anbio BiotechnologyDaily Exit and Entry Price Prediction - Newser
Alnylam Pharmaceuticals Skyrocketed 16.26%—Can This Biotech Breakout Sustain Momentum? - AInvest
Anbio Biotechnology's 15min chart sees KDJ Golden Cross and Bullish Marubozu - AInvest
Why Churchill Capital Corp IX stock attracts strong analyst attentionChart Confirmation Setup with ROI Signals - Newser
Using fundamentals and technicals on CDNSFree Daily Picks With Predictable Performance - Newser
Anbio Biotechnology Plunges 8.67%, What Storm Is Brewing in the Diagnostics Sector? - AInvest
Inmune Bio shares fall 2.53% premarket after announcing a video detailing MINDFuL trial findings. - AInvest
Is Anbio Biotechnology Stock a Smart Buy in 2025 Investment Analysis InsideYield Curve Outlook and Long-Term Implication Summary - Newser
Anbio Biotechnology Trading Near Value Zone — Recovery AheadPattern Detection for Entry Confirmation Enabled - metal.it
Technical signs of recovery in Anbio BiotechnologyAI Powered Buy Point Forecast Planner - Newser
How high can ICMB stock price go in 2025Free Early Breakout Entry Point Notifications - Newser
Comparing Anbio Biotechnology in custom built stock radarsConservative Investment Setup and Risk Analysis - Newser
Anbio Biotechnology (NNNN) 財務データ
Anbio Biotechnology (NNNN) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):